chemie.pr-Abbott's Kaletra(R) Tablet Dosed Once-Daily Or Twice-Daily Demonstrated ...
Abbotts KaletraR Tablet Dosed Once,Daily Or Twice,Daily Demonstrated Similar Clinical Results Across Race And Gender Lines , Pharmaceutical News
Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
05.08.2008 21:40:05
Abbott Laboratories: Mexico City (ots/PRNewswire) - - HIV-Infected Women and Non-Whites New to Antiretroviral Therapy Respond Similarly to Men and Whites Initial treatment regimens containing once-daily or twice-daily dosing of Abbott's (NYSE: ...
Lesen Sie hier weiter... |
Drucken |
PDF
Ähnliche Artikel
- Results From the SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) Study
- Eisai's Commitment to Oncology Demonstrated by Clinical Data to be Presented at ASCO Annual Meeting
- Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule
- European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naïve Adults With HIV-1
- Almirall and Forest Laboratories Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel Long-Acting Anticholinergic for the Treatment for COPD
- ATHENA Clinical Results for Dronedarone (Multaq(R)) Highlighted at the World Cardiology Congress
- FDA Approves Abbott's XIENCE(TM) V Drug Eluting Stent
- New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa
- Sanofi Aventis : New Study Results Support the"Basal Plus" Strategy With LANTUS(R) and APIDRA(R) to Improve Blood Sugar Control in Patients With Type 2 Diabetes
- New Pegasys Data Show Hepatitis B Patients Achieve Highly Positive Treatment Response That Comes as Close to a Cure as Possible
2008 August 05 | Aktuelle News aus Deutschland und der Welt
ots: Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines.Mexico City (ots
ots.at: das APA-OTS-Portal für multimediale Presseaussendungen
Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results.Across Race and Gender Lines = 05.08.2008 / 21:28
Presseportal: Abbott Laboratories - Abbott kündigt Zulassung für ersten ...
Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines
Die Physiker der Universität von KwaZulu-Natal gehen als die Gründert ...
Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines